[Down syndrome maternal serum screening: results' comments recommended by accredited biologists]

J Gynecol Obstet Biol Reprod (Paris). 2014 Nov;43(9):671-9. doi: 10.1016/j.jgyn.2014.05.012. Epub 2014 Sep 11.
[Article in French]

Abstract

Down syndrome maternal serum screening is largely used in France. The aim of this article is to specify and to explain the different comments applied on the reports in order to optimize the management of the patient. These comments represent the consensus of the study group of the biologist accredited for Down syndrome maternal serum screening.

Keywords: AFP; Dépistage sérique; Maternal serum screening; PAPP-A; Pregnancy management; Suivi de grossesse; Trisomie 21; Trisomy 21; hCG; hCGβ.

MeSH terms

  • Biomarkers / blood
  • Chorionic Gonadotropin, beta Subunit, Human / blood
  • Consensus
  • Down Syndrome / blood*
  • Female
  • France
  • Humans
  • Pregnancy
  • Pregnancy Trimester, First
  • Pregnancy-Associated Plasma Protein-A / analysis
  • Prenatal Diagnosis / methods*
  • Risk
  • alpha-Fetoproteins / analysis

Substances

  • Biomarkers
  • Chorionic Gonadotropin, beta Subunit, Human
  • alpha-Fetoproteins
  • Pregnancy-Associated Plasma Protein-A
  • PAPPA protein, human